Lexpos News

The Department of Health and Social Care (DHSC) has confirmed that prescriptions for Cleen Ready-to-use 133ml enema (Sodium dihydrogen phosphate dihydrate 18.1% / Disodium hydrogen phosphate dodecahydrate 8% 133ml enema) dispensed in November and December 2025 will be correctly reimbursed based on its increased NHS list price which had not been reflected in the published [...]

The post Cleen Ready-to-use enema Drug Tariff price adjustment – November and December 2025 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) and the NHS have launched a new campaign encouraging all adults to take the new NHS Healthy Choices Quiz. This health and wellbeing quiz aims to empower adults to take control of their health by making small changes day to day. The quiz, which takes around 5 [...]

The post New NHS Healthy Choices Quiz appeared first on Community Pharmacy England.

Pharmacy owners have until 3rd February 2026 to start the Pharmacy Quality Scheme (PQS) Antimicrobial Stewardship – Pharmacy First consultations – Clinical Audit. The audit, which is a quality criterion in the Patient safety domain of the 2025/26 PQS, requires pharmacy owners to complete a clinical audit focused on the clinical advice and consultations provided to patients [...]

The post PQS: Have you started your AMS Pharmacy First audit? appeared first on Community Pharmacy England.

Daily Express There have been media reports today in the Daily Express highlighting growing pharmacy pressures and closures across England and Wales. Figures from the Independent Pharmacies Association (IPA) indicate hundreds of pharmacies have closed, with warnings that recent tax and cost pressures are forcing many out of business. Rachel Reeves accused of pushing pharmacies [...]

The post Pharmacy pressures: tax rises are driving more closures across the country appeared first on Community Pharmacy England.

The MHRA has reviewed the warnings regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs. The findings (detailed in the Public Assessment Report) were that it was necessary to strengthen these warnings in the product information and on packaging to better inform healthcare professionals and patients of these known risks. Advice for [...]

The post MHRA Drug Safety Update: Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs appeared first on Community Pharmacy England.